Loading...
Peritoneal tuberculosis presenting as recurrent peritonitis secondary to treatment with intravesical Bacillus Calmette-Guérin in a patient receiving peritoneal dialysis.
Iqbal, Junaid Raja, Maria Leung, Janson
Iqbal, Junaid
Raja, Maria
Leung, Janson
Abstract
Intravesical Bacillus Calmette-Guérin (BCG) is an established treatment for high-risk superficial bladder cancer [Morales A, Eidinger D, Bruce AW. Intracavitary Bacillus Calmette-Guérin in the treatment of superficial bladder tumors.1976. J Urol 2002; 167: 891-893, Lamm DL, van der Meijden APM, Morales A et al. Incidence and treatment of complications of Bacillus Calmette-Guérin intravesical therapy in superficial bladder cancer. J Urol 1992; 147: 596-600]. We describe a patient receiving peritoneal dialysis (PD), who developed peritoneal tuberculosis following treatment of bladder cancer with intravesical BCG instillations. To the best of our knowledge, this is the first case of peritoneal tuberculosis following intravesical BCG treatment in which the mycobacterium has been typed and confirmed as a BCG strain with genetic analysis.
MIDER Authors
Citations
Altmetric:
Date
2015-02
Type
Article
Subject
Nephrology/Renal medicine
Collections
Citation
Clin Kidney J. 2015 Feb;8(1):107-8. doi: 10.1093/ckj/sfu137. Epub 2014 Dec 30.
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Files
Loading...
(149) Clin Kid J.pdf
Adobe PDF, 68.14 KB